JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB258883

Human GIPC1 knockout HEK-293T cell lysate

Be the first to review this product! Submit a review

|

(0 Publication)

GIPC1 KO cell lysate available now. KO validated. Free of charge wild type control included. Knockout achieved by using CRISPR/Cas9, Insertion of the selection cassette in exon5.
1 Images
Sanger Sequencing - Human GIPC1 knockout HEK-293T cell lysate (AB258883)
  • Sanger seq

Unknown

Sanger Sequencing - Human GIPC1 knockout HEK-293T cell lysate (AB258883)

Homozygous : Insertion of the selection cassette in exon5

Key facts

Cell type

HEK-293T

Species or organism

Human

Tissue

Kidney

Knockout validation

Sanger Sequencing

Mutation description

Knockout achieved by using CRISPR/Cas9, Insertion of the selection cassette in exon5.

Product details

Knockout cell lysate achieved by CRISPR/Cas9.

REACH authorisation
Abcam has not and does not intend to apply for the REACH Authorisation of customers' uses of products that contain European Authorisation list (Annex XIV) substances.
It is the responsibility of our customers to check the necessity of application of REACH Authorisation, and any other relevant authorisations, for their intended uses.

Lysate preparation: Our lysates are made using RIPA buffer to which we add a protease inhibitor cocktail and phosphatase inhibitor cocktail (ratio: 300:100:10). This means that the protein of interest is denatured. If you require a native form of the protein please use the live cell version. Please refer to our lysis protocol for further details on how our lysates are prepared.

User storage instructions: Lyophilizate may be stored at 4°C. After reconstitution, store at -20°C for short-term storage or -80°C for long-term storage.

This product is subject to limited use licenses from The Broad Institute, ERS Genomics Limited and Sigma-Aldrich Co. LLC, and is developed with patented technology. For full details of the licenses and patents please refer to our limited use license and patent pages.

What's included?

{ "values": { "1Kit": { "sellingSize": "1 Kit", "publicAssetCode":"ab258883-1Kit", "assetComponentDetails": [ { "size":"1 x 100 µg", "name":"Human GIPC1 knockout HEK293T cell lysate", "number":"AB258883-CMP01", "productcode":"" }, { "size":"1 x 100 µg", "name":"Human wild-type HEK293T cell lysate", "number":"AB258883-CMP02", "productcode":"" } ] } } }

Properties and storage information

Gene name
GIPC1
Gene editing type
Knockout
Gene editing method
CRISPR technology
Knockout validation
Sanger Sequencing
Shipped at conditions
Ambient - Can Ship with Ice
Appropriate short-term storage conditions
-20°C
Appropriate long-term storage conditions
-20°C

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

The protein GIPC1 also known as GAIP-interacting protein C terminus 1 weighs approximately 36 kDa. It functions mechanically as an adaptor protein binding to PDZ domains. Expressed widely throughout tissues GIPC1 shows high expression in the brain and heart. Acting at the cellular level it plays vital roles in receptor sorting and signal transduction through interactions with various cell surface proteins.
Biological function summary

The function of GIPC1 extends to endocytosis and cell signaling. It often forms part of protein complexes that facilitate intracellular trafficking. By interacting with membrane receptors like integrins and receptor tyrosine kinases GIPC1 aids in cell communication and adhesion processes. Its presence impacts the development and maintenance of cellular structures due to these complex formations.

Pathways

GIPC1 participates significantly in both the Wnt signaling and Ras signaling pathways. It associates with Dishevelled proteins in the Wnt pathway contributing to modulation of cell fate and proliferation. Additionally it connects to Ras-related signaling where it interacts with receptors such as the insulin-like growth factor receptor (IGF1R) thereby mediating downstream signaling effects important for cell growth and differentiation.

GIPC1 presents connections to cancer and diabetic retinopathy. In cancer aberrant GIPC1 expression influences tumor progression and metastasis by interacting with proteins like Ras and IGF1R affecting cellular proliferation and survival mechanisms. For diabetic retinopathy GIPC1 modulates angiogenic signals potentially through its partnerships with vascular endothelial growth factor receptor (VEGFR) pathways which leads to pathological neovascularization associated with vision impairment.

Quality control

STR analysis

CSF1PO, D13S317, D7S820, D5S818, TH01, D16S539, TPOX

Cell culture

Biosafety level

EU: 2 US: 2

Adherent/suspension

Adherent

Gender

Female

Product protocols

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com